Actinium Pharmaceuticals, Inc. (Delaware)Actinium Pharmaceuticals, Inc. (Delaware)Actinium Pharmaceuticals, Inc. (Delaware)

Actinium Pharmaceuticals, Inc. (Delaware)

No trades
See on Supercharts
Market capitalization
‪264.57 M‬USD
−1.84USD
‪−48.82 M‬USD
‪81.00 K‬USD
‪28.26 M‬
Beta (1Y)
0.62

About Actinium Pharmaceuticals, Inc. (Delaware)

CEO
Sandesh Seth
Headquarters
New York
Employees (FY)
49
Founded
2000
ISIN
US00507W2061
FIGI
BBG000RQZ245
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or refractory cancer patients. The company was founded in 2000 and is headquartered in New York, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ATNM is 9.00 USD — it has decreased by 0.99% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Actinium Pharmaceuticals, Inc. (Delaware) stocks are traded under the ticker ATNM.
Actinium Pharmaceuticals, Inc. (Delaware) is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Actinium Pharmaceuticals, Inc. (Delaware) has a max estimate of 50.00 USD and a min estimate of 16.00 USD.
ATNM earnings for the last quarter are −0.49 USD whereas the estimation was −0.51 USD which accounts for 4.71% surprise. Estimated earnings for the next quarter are −0.57 USD. See more details about Actinium Pharmaceuticals, Inc. (Delaware) earnings.
Actinium Pharmaceuticals, Inc. (Delaware) revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach ‪575.00 K‬ USD.
Yes, you can track Actinium Pharmaceuticals, Inc. (Delaware) financials in yearly and quarterly reports right on TradingView.
Like other stocks, ATNM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Actinium Pharmaceuticals, Inc. (Delaware) stock right from TradingView charts — choose your broker and connect to your account.
ATNM reached its all-time high on Apr 3, 2014 with the price of 450.00 USD, and its all-time low was 3.00 USD and was reached on Jun 1, 2012.
See other stocks reaching their highest and lowest prices.
As of Apr 14, 2024, the company has 49.00 employees. See our rating of the largest employees — is Actinium Pharmaceuticals, Inc. (Delaware) on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Actinium Pharmaceuticals, Inc. (Delaware) EBITDA is ‪−51.13 M‬ USD, and current EBITDA margin is ‪−63.12 K‬%. See more stats in Actinium Pharmaceuticals, Inc. (Delaware) financial statements.